Document is current

Hrdinka, Matous https://orcid.org/0000-0002-2981-2825

Schlicher, Lisa

Dai, Bing

Pinkas, Daniel M

Bufton, Joshua C

Picaud, Sarah

Ward, Jennifer A

Rogers, Catherine

Suebsuwong, Chalada

Nikhar, Sameer

Cuny, Gregory D

Huber, Kilian VM https://orcid.org/0000-0002-1103-5300

Filippakopoulos, Panagis

Bullock, Alex N

Degterev, Alexei https://orcid.org/0000-0002-8240-7132

Gyrd‐Hansen, Mads https://orcid.org/0000-0001-5641-5019

Funding for this research was provided by:

Eshelman Institute for Innovation, University of North Carolina at Chapel Hill

Allergopharma

Novartis Pharma

Wellcome Trust (106169/ZZ14/Z, 095751/Z/11/Z, 102894/Z/13/Z)

Takeda Pharmaceutical Company

Forskerakademiet

Ministerstvo Vnitra České Republiky (18‐24070Y)

European Molecular Biology Organization

Ludwig Institute for Cancer Research

AbbVie

Bayer

Boehringer Ingelheim

Canada Foundation for Innovation

Genome Canada

Erzincan Üniversitesi (ULTRA‐DD 115766)

Meso Scale Diagnostics

Ontario Ministry of Economic Development and Innovation

Pfizer

Fundação de Amparo à Pesquisa do Estado de São Paulo

Myeloma UK

American Heart Association (15GRNT22970025)

National Institutes of Health (R01CA190542, R21AI124049)

Version of Record valid from 2018-07-19